| abstract |
(57) [Summary]nThe present invention is directed to the treatment of atherosclerotic plaques in mammals, directly and indirectly, using appropriate substances capable of lipid removal, primarily by hydrolysis by catalytic or stoichiometric processes. , A method of reducing and / or eliminating these plaques, wherein the substance targets a receptor in and / or on cells that directs uptake into lysosomes. Such materials used to reduce and / or eliminate atherosclerotic plaque are generally composed of lipid hydrolyzable proteins and / or polypeptides. |